Systems and methods for treating coronavirus
US-2024131003-A1 · Apr 25, 2024 · US
US9616194B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9616194-B2 |
| Application number | US-201213431827-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 27, 2012 |
| Priority date | Jun 22, 2011 |
| Publication date | Apr 11, 2017 |
| Grant date | Apr 11, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
In accordance with the present invention, there is provided a mask for achieving positive pressure mechanical ventilation (inclusive of CPAP, ventilator support, critical care ventilation, emergency applications), and a method for a operating a ventilation system including such mask. The mask of the present invention includes a piloted exhalation valve that is used to achieve the target pressures/flows to the patient. The pilot for the valve may be pneumatic and driven from the gas supply tubing from the ventilator. The pilot may also be a preset pressure derived in the mask, a separate pneumatic line from the ventilator, or an electro-mechanical control. Additionally, the valve can be implemented with a diaphragm or with a flapper.
Opening claim text (preview).
What is claimed is: 1. A method of ventilating a patient utilizing a direct nasal interface mask worn by the patient and fluidly connected to a ventilator adapted to supply a pressurized, breathable gas to the direct nasal interface mask, the method comprising the steps of: a) providing the direct nasal interface mask with a housing defining at least one flow passage, and a piloted exhalation valve is integrated into the housing and fluidly coupled to the flow passage; and b) applying a pilot pressure to the exhalation valve via the ventilator and in a manner which facilitates the selective movement thereof from an open position to which it is normally biased and wherein at least a portion of the flow passage is vented to ambient air, to a closed position wherein fluid flow between the flow passage and ambient air is at least partially obstructed thereby. 2. The method of claim 1 wherein step (a) comprises configuring the exhalation valve to completely obstruct fluid flow between the flow passage and ambient air when moved to the closed position in step (b). 3. The method of claim 1 wherein step (a) comprises configuring the exhalation valve to vent the entirety of the flow passage to ambient air when moved to the open position in step (b). 4. The method of claim 1 wherein step (a) comprises configuring the exhalation valve to adjust fluid flow between the flow passage and ambient air when disposed between the closed position and open position in step (b). 5. The method of claim 1 wherein step (a) comprises configuring the housing to include a pressure sensing port, and step (b) comprises sensing pressure within the flow passage through the use of the pressure sensing port to facilitate at least one of achieving and monitoring a therapeutic pressure level therein. 6. The method of claim 1 wherein step (a) comprises configuring the exhalation valve to include a diaphragm which is movable between the closed and open positions in step (b). 7. The method of claim 1 wherein step (a) comprises configuring the exhalation valve to include at least one flapper which is movable between the closed and open positions in step (b). 8. The method of claim 1 wherein step (b) comprises initially supplying no pressurized, breathable gas from the ventilator to the patient via the direct nasal interface mask. 9. The method of claim 8 further comprising the step of: c) initiating the delivery of the pressurized, breathable gas from the ventilator to the patient at a prescribed therapeutic pressure level upon an occurrence of a predetermined event. 10. The method of claim 9 wherein the predetermined event of step (c) is at least one of: an elapse of a set time interval; a detection of a patient breathing pattern indicative of an airway obstruction in the patient; and a detection of a patient breathing pattern indicative of the patient falling asleep. 11. A method of ventilating a patient using a direct nasal interface mask worn by the patient and fluidly connected to a ventilator adapted to supply a pressurized, breathable gas to the direct nasal interface mask, the method comprising the steps of: a) providing the direct nasal interface mask with a housing at least partially defining a valve chamber which fluidly communicates with ambient air, a pilot port which fluidly communicates with the valve chamber, at least one flow passage which is selectively placeable into fluid communication with the valve chamber, and a diaphragm which is disposed within the valve chamber and selectively movable from an open position to which it is normally biased and wherein the flow passage is vented to ambient air via the valve chamber, to a closed position wherein fluid flow between the flow passage and the valve chamber is obstructed thereby; and b) using the pilot port to selectively apply a pilot pressure from the ventilator to the diaphragm in a manner facilitating the movement thereof to the closed position. 12. The method of claim 11 wherein step (a) comprises configuring the housing to include a pressure sensing port which fluidly communicates with the flow passage, and step (b) comprises sensing pressure within the flow passage through the use of the pressure sensing port to facilitate at least one of achieving and monitoring a therapeutic pressure level therein. 13. The method of claim 11 wherein step (b) further comprises initially supplying no pressurized, breathable gas from the ventilator to the patient via the direct nasal interface mask, and initially supplying no pilot pressure from the ventilator to the diaphragm. 14. The method of claim 13 further comprising the step of: c) initiating the delivery of the pressurized, breathable gas from the ventilator to the patient at a prescribed therapeutic pressure level upon an occurrence of a predetermined event. 15. The method of claim 14 wherein the predetermined event of step (c) is at least one of: (i) an elapse of a set time interval; (ii) a detection of a patient breathing pattern indicative of an airway obstruction in the patient; and (iii) a detection of a patient breathing pattern indicative of the patient falling asleep. 16. The method of claim 13 further comprising the steps of: c) initiating the delivery of the pressurized, breathable gas from the ventilator to the direct nasal interface mask through the use of tubing having an inner diameter in the range of from about 1 mm to about 9 mm; and d) delivering the pressurized, breathable gas from the ventilator to the direct nasal interface mask through the tubing at a delivery pressure level which exceeds a prescribed therapeutic pressure level for the delivery of the pressurized, breathable gas from the direct nasal interface mask to the patient.
T- or Y-type connectors, e.g. Y-piece · CPC title
Connecting tubes · CPC title
Controlled valves · CPC title
Measuring or controlling the flow rate · CPC title
Membrane valves with pneumatic amplification stage, i.e. having leader and follower membranes · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.